Skip to content

Effect of thermal softening pretreatment of double-lumen endobronchial tube combined with magnesium sulfate gargle on postoperative sore throat

Effect of thermal softening pretreatment of double-lumen endobronchial tube combined with magnesium sulfate gargle on postoperative sore throat

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072980
Enrollment
Unknown
Registered
2023-06-29
Start date
2023-07-01
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary, mediastinal or chest wall surgery

Interventions

M group:Magnesium sulfate (20 mg/kg) was diluted with normal saline to 30 mL and rinsed for 1 minutes 15 minutes before anesthesia induction. DLT was immersed in sterile normal saline at (24 ± 1) degr
T group:Normal saline 30 mL was given 15 minutes before induction of anesthesia for 1 minutes. DLT was immersed in sterile normal saline at (40 ± 1) degrees Celsius for 10 minutes before tracheal intu
SN group:Normal saline 30 mL was given 15 minutes before induction of anesthesia for 1 minutes , and DLT was immersed in sterile saline at (24 ± 1) degrees Celsius for 10 minutes before tracheal intub
MT group:Magnesium sulfate (20 mg/kg) was diluted with normal saline to 30 mL and rinsed for 1 minutes 15 minutes before anesthesia induction. DLT was immersed in (40 ± 1) degrees Celsius sterile norm

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective thoracic surgery with double-lumen endobronchial intubation under general anesthesia and undergoing pulmonary, mediastinal or chest wall surgery; 2. Aged >= 18 years; 3. American Society of Anesthesiologists (ASA) I-III.

Exclusion criteria

Exclusion criteria: 1. Preexisting sore throat and hoarseness; 2. The history of upper respiratory tract infection in the past 1 week; 3. Patients with known intubation difficulties, including mouth opening less than 3.5 cm, Mallampati grade 3-4, head backward limitation; 4. Steroids and non-steroidal anti-inflammatory drugs were used within 3 days before surgery; 5. Allergic to magnesium sulfate; 6. The nasogastric tube was inserted 24 hours before operation or within 24 hours after operation.

Design outcomes

Primary

MeasureTime frame
Incidence of sore throat;

Secondary

MeasureTime frame
Incidence of sore throat;Severity of sore throat;The incidence and severity of hoarseness;The 15-item quality of recovery scale ( QoR-15 ) scores;Length of postoperative hospital stay;Incidence of pulmonary complications;patient satisfaction;

Countries

China

Contacts

Public ContactLiu Jindong

The Affiliated Hospital of Xuzhou Medical University

Liujindong1818@163.com+86 139 5135 5136

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026